Rhythm Pharmaceuticals, Inc. (BMV:RYTM)

Rhythm Pharmaceuticals Revenue

Rhythm Pharmaceuticals had revenue of $51.30M USD in the quarter ending September 30, 2025, with 54.28% growth. This brings the company's revenue in the last twelve months to $174.33M, up 54.92% year-over-year. In the year 2024, Rhythm Pharmaceuticals had annual revenue of $130.13M with 68.06% growth.

• Revenue (ttm): $174.33M
• Revenue Growth: +54.92%
• P/S Ratio: 39.72
• Revenue / Employee: $616.02K
• Employees: 283
• Market Cap: 127.01B MXN

Revenue Chart

* This company reports financials in USD.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	130.13M	52.70M	68.06%
Dec 31, 2023	77.43M	53.79M	227.56%
Dec 31, 2022	23.64M	20.48M	649.46%
Dec 31, 2021	3.15M	-	-
Dec 31, 2020	-	-	-